Rugged Raccoon

  • 19 Posts
  • 9 Comments
Joined 4 years ago
cake
Cake day: January 14th, 2021

help-circle







  • It’s not just about the production capacity of India. India currently has two vaccines - Covishield (Oxford & AstraZeneca developed, manufactured by Serum Institute of India) and Covaxin (Indian Council of Medical Research & Bharat BioTech, manufactured by Bharat BioTech). Sputnik V is a new addition from Russia.

    While it would be wise to blame the country for the under production of Covaxin, because it’s a home grown vaccine and public money was involved in its development. It could’ve been manufactured by more than one manufacturer in the country.

    But, in case of Covishield, only SII has the license to manufacture it. If the IP rules are to be waived, it could be manufactured by others in the country.

    The whole point is, countries like India have the capability to mass produce vaccines to satisfy domestic needs and to help other countries that don’t have the necessary facilities to do so. The rich countries have secured enough vaccines (How rich countries are making the pandemic last longer) and in the case of UK, they have clause in the vaccine contracts to give it more preference, should the producer face shortages (link).






















  • But, we could install a version of signal client that’s not compromised, which sends as little as possible, encrypted. So, a compromised server could deny the requests, because the client was modified or it couldn’t work with the encrypted content the way it expected. This would automatically raise red flags, because the app doesn’t work anymore. Has something like this happened?

    And for the deploying modified versions to targeted devices. I know it’s possible through orders or compromised server, but has it happened? If so, any sources regarding that.